Notify me when Wajdi Abdul-Ahad files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AIXC | Qualigen Therapeutics, Inc. | Vice President, R & D, CSO | 11 Jul 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|